APOE2: protective mechanism and therapeutic implications for Alzheimer's disease

Z Li, F Shue, N Zhao, M Shinohara, G Bu - Molecular neurodegeneration, 2020 - Springer
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for
Alzheimer's disease (AD), have yielded significant insights into the pathogenic mechanism …

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

CC Liu, T Kanekiyo, H Xu, G Bu - Nature Reviews Neurology, 2013 - nature.com
Abstract Apolipoprotein E (Apo-E) is a major cholesterol carrier that supports lipid transport
and injury repair in the brain. APOE polymorphic alleles are the main genetic determinants …

The vascular depression hypothesis: mechanisms linking vascular disease with depression

WD Taylor, HJ Aizenstein, GS Alexopoulos - Molecular psychiatry, 2013 - nature.com
Abstract The 'Vascular Depression'hypothesis posits that cerebrovascular disease may
predispose, precipitate or perpetuate some geriatric depressive syndromes. This hypothesis …

Development and aging of cortical thickness correspond to genetic organization patterns

AM Fjell, H Grydeland, SK Krogsrud… - Proceedings of the …, 2015 - National Acad Sciences
There is a growing realization that early life influences have lasting impact on brain function
and structure. Recent research has demonstrated that genetic relationships in adults can be …

The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2

S Suri, V Heise, AJ Trachtenberg, CE Mackay - … & Biobehavioral Reviews, 2013 - Elsevier
Ongoing efforts to improve survival, and enhance quality of life have led biomedical
research to focus on disease and the mechanisms that increase risk for disease. The other …

HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework

E Varol, A Sotiras, C Davatzikos… - Neuroimage, 2017 - Elsevier
Multivariate pattern analysis techniques have been increasingly used over the past decade
to derive highly sensitive and specific biomarkers of diseases on an individual basis. The …

[HTML][HTML] Predictors of ageing-related decline across multiple cognitive functions

SJ Ritchie, EM Tucker-Drob, SR Cox, J Corley… - Intelligence, 2016 - Elsevier
It is critical to discover why some people's cognitive abilities age better than others'. We
applied multivariate growth curve models to data from a narrow-age cohort measured on a …

Alzheimer's disease genetic risk factor APOE-ε4 also affects normal brain function

AM Di Battista, NM Heinsinger… - Current Alzheimer …, 2016 - ingentaconnect.com
APOE-4 is the strongest genetic risk factor for Alzheimer's disease (AD), and is associated
with an increase in the levels of amyloid deposition and an early age of onset. Recent data …

[HTML][HTML] APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

I Reinvang, T Espeseth, LT Westlye - Neuroscience & Biobehavioral …, 2013 - Elsevier
Individuals carrying the* E4 allele of the apolipoprotein E gene (APOE) are at increased risk
of developing Alzheimer's disease (AD). However, the biological mechanisms underlying …

Machine learning based on Optical Coherence Tomography images as a diagnostic tool for Alzheimer's disease

X Wang, B Jiao, H Liu, Y Wang, X Hao… - CNS Neuroscience …, 2022 - Wiley Online Library
Aims We mainly evaluate retinal alterations in Alzheimer's disease (AD) patients, investigate
the associations between retinal changes with AD biomarkers, and explore an optimal …